Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Role of chemotherapy in clinical T2N0M0 gastric cancer.
Authors
Sawyer Bawek
University at Buffalo, Department of Internal Medicine, Buffalo, NY;
Sawyer Bawek , Yeshwanth Vedire , Adrienne Groman , Sarbajit Mukherjee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 308)
DOI
10.1200/JCO.2023.41.4_suppl.308
Abstract #
308
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Adjuvant treatment for resected sub-centimeter T1 pancreatic cancer.
First Author: Walid Labib Shaib
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of survival outcomes in patients with pancreatic cancer who underwent upfront surgery.
First Author: Jae Hyup Jung
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
First Author: Joon Oh Park
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Treatment sequencing for patients with localized duodenal and ampullary adenocarcinoma.
First Author: Abhishek Janardan